Latest Foundation Venture Capital Group Stories

2014-10-14 12:30:31

NEW BRUNSWICK, N.J., Oct. 14, 2014 /PRNewswire-USNewswire/ -- Actinobac Biomed Inc., has received a $905,040 Small Business Technology Transfer Grant (STTR) Phase II Award from the National Institutes of Health/ National Cancer Institute to continue to develop its drug candidate, Leukothera®, as a potential treatment for B-cell lymphomas. "This NIH grant supports our assertion that Actinobac scientists are working on breakthrough research that can make a tremendous difference for...

2014-01-08 12:30:06

NEW BRUNSWICK, N.J., Jan. 8, 2014 /PRNewswire-USNewswire/ -- James M. Golubieski, president of New Jersey Health Foundation (NJHF) and Foundation Venture Capital Group (FVCG), discussed how these organizations promote the commercialization of research in New Jersey as he addressed a panel at the Research Efficiency Conference in Washington, DC, sponsored by the Association of Academic Health Centers. At a session "Looking Beyond the NIH" that explored alternate funding sources, Mr....

2011-08-03 16:56:00

NEW BRUNSWICK, N.J., Aug. 3, 2011 /PRNewswire-USNewswire/ -- A new diagnostic test for Alzheimer's disease (AD) developed by biotech company Durin Technologies in New Jersey has shown promising results using antibody biomarkers in a drop of blood to identify presence of the disease, according to findings that appear online in PLoS ONE. The research was made possible through an investment by Foundation Venture Capital Group (FVCG), LLC, a New Jersey Health Foundation affiliate that invests...

Word of the Day
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).